Chairman Scott, Ranking Member Gillibrand Set Hearing to Expose China’s Control of America’s Drug Supply

WASHINGTON, D.C. - On Wednesday, March 11, Chairman Rick Scott and Ranking Member Kirsten Gillibrand will convene a hearing entitled "Foreign Dependence: How China Captured America's Drug Supply." This hearing will expose how China is deliberately pursuing global dominance in pharmaceutical manufacturing through state-directed industrial policy, and how U.S. trade, regulatory, and procurement decisions contribute to the erosion of America's domestic production capacity. Members and expert witnesses will discuss how China now controls critical aspects of the global drug supply chain -- from active pharmaceutical ingredients to finished generics -- creating a dangerous overreliance for the U.S., and particularly for America's aging community that relies on these essential medications to live happy, healthy lives.

This hearing builds on the Committee's bipartisan efforts under Chairman Scott and Ranking Member Gillibrand's leadership to identify the policy failures that have enabled America's foreign overreliance and advocate for advancing reforms that restore American control over these essential medicines. As part of this effort, members will highlight the importance of the bipartisan and bicameral CLEAR LABELS Act, which will improve transparency by requiring clear and upfront disclosure of where the medicines Americans rely on are coming from.

Witnesses for the hearing will include:

• Hon. Ted Yoho, Former U.S. Congressman, Senior Advisor, Kyle House Group, Welaka, FL

• Gordon G. Chang, Author, Plan Red: China's Project to Destroy America, Bedminster, NJ

• Rosemary Gibson, Author, China Rx, McLean, VA

• Chan Harjivan, Visiting Fellow, Duke Margolis Institute for Health Policy, Washington D.C.

WHEN: Wednesday, March 11, 2026

3:30PM ET

WHERE: Hart Senate Office Building, SH-216

WATCH: Live broadcast online HERE.

See below to read more about the U.S. Senate Special Committee on Aging's bipartisan work:

• 03/04/26: Chairman Scott, Ranking Member Gillibrand Press America's Pharmacies on U.S. Drug Supply Chain and Country-of-Origin Labeling for Foreign-Made Drugs
• 02/19/26: Chairman Scott Sends Letter to Secretary Hegseth on Securing Generic Drug Supply for Service Members and Veterans
• 01/29/26: Chairman Scott Calls for Transparency of Foreign-Made Generic Drugs, Announces CLEAR LABELS Act to Require Country-of-Origin Labeling
• 11/19/25: Chairman Scott Leads Aging Hearing on Navigating Path to Restoring U.S. Leadership in Essential Drug Manufacturing
• 10/30/25: Chairman Scott, Ranking Member Gillibrand Send Letter to Pharmaceutical Distributor Executives on Regulatory Oversight of Foreign-Manufactured Generic Drugs
• 10/29/25: Chairman Scott, Ranking Member Gillibrand Send Letter to Group Purchasing Organization Executives on Regulatory Oversight of Foreign-Manufactured Generic Drugs
• 10/24/25: Chairman Scott, Ranking Member Gillibrand Pen Letter to HHS on Dangers of Overreliance on Foreign-Manufactured Generic Drugs and Request Information on HHS's Efforts to Combat Vulnerabilities
• 10/20/25: Chairman Scott, Ranking Member Gillibrand Release Investigative Report Exposing America's Dangerous Overreliance on Foreign-Made Generic Drugs, Proposing Bipartisan Policy Recommendations
• 10/08/25: Chairman Scott Leads Aging Committee Hearing on Closing Deadly Generic Drug Loopholes and Rebuilding America's Essential Medicine Supply
• 09/17/25: Chairman Scott: U.S. Overdependence on Foreign-Manufactured Generic Drugs Threatens Lives of America's Seniors & National Security

###